Certara GlobalSubmit eCTD software Overview

Globalsubmit provides eCTD submission software to mitigate rejection risks in a complex regulatory environment. Differences in regulatory requirements complicate the submission process.

Use Cases

Customers recommend Sending & Publishing Communications, Workflow Management, Onboarding, as the business use cases that they have been most satisfied with while using Certara GlobalSubmit eCTD software.

Other use cases:

  • Content Management
  • Social Media Analytics
  • Trust Management
  • Engagement Management
  • Competitive Intelligence
  • Products & Pricelist Management
  • Product Marketing
See all use cases See less use cases

Business Priorities

Scale Best Practices and Launch New Products are the most popular business priorities that customers and associates have achieved using Certara GlobalSubmit eCTD software.

Other priorities:

  • Improve Efficiency
See all business priorities See less business priorities

Certara GlobalSubmit eCTD software Use-Cases and Business Priorities: Customer Satisfaction Data

Certara GlobalSubmit eCTD software's features include Templates. and Certara GlobalSubmit eCTD software support capabilities include 24/7 Support, Email Support, Chat Support, etc. also Certara GlobalSubmit eCTD software analytics capabilities include Custom Reports, and Analytics.

Reviews

"...GlobalSubmits approach to document management is a familiar one intuitive interface, easy implementation that appeals to the novice user, built-in templates and workflows, and integration with eCTD publishing systems...." Peer review

Popular Business Setting

for Certara GlobalSubmit eCTD software

Top Industries

  • Pharmaceuticals

Popular in

  • Enterprise

Certara GlobalSubmit eCTD software is popular in Pharmaceuticals, and is widely used by Enterprise,

Certara GlobalSubmit eCTD software Customer wins, Customer success stories, Case studies

What Are the key features of Certara GlobalSubmit eCTD software for Sending & Publishing Communications?

How can Certara GlobalSubmit eCTD software enhance your Workflow Management process?

What solutions does Certara GlobalSubmit eCTD software provide for Onboarding?

What solutions does Certara GlobalSubmit eCTD software provide for Content Management?

11 buyers and buying teams have used Cuspera to assess how well Certara GlobalSubmit eCTD software solved their business needs. Cuspera uses 376 insights from these buyers along with peer reviews, customer case studies, testimonials, expert blogs and vendor provided installation data to help you assess the fit for your specific business needs.

lightning

Peers used Certara GlobalSubmit eCTD software for sending & publishing communications and workflow management

Certara GlobalSubmit eCTD software Features

  • Low
  • Medium
  • High
FEATURE RATINGS AND REVIEWS
Custom Reports

4.34/5 ★

Read Reviews (48)
Analytics

3.26/5 ★

Read Reviews (1)
CAPABILITIES RATINGS AND REVIEWS
Custom Reports

4.34/5 ★

Read Reviews (48)
Analytics

3.26/5 ★

Read Reviews (1)

Software Failure Risk Guidance

?

for Certara GlobalSubmit eCTD software

Overall Risk Meter

Low Medium High

Top Failure Risks for Certara GlobalSubmit eCTD software

Certara, USA. News

Financial

Certara Conference: 2025 revenue hits guidance, EBITDA margin tops ...

Certara reported 2025 organic software revenue growth of 7% and an adjusted EBITDA margin of 32%, despite a decline in Q4 software bookings. The company launched three new software offerings: Certara IQ for QSP, Phoenix Cloud, and a Pinnacle enhancement. These launches are expected to drive growth in 2026. Certara also highlighted its AI strategy and potential changes in its regulatory services segment.

Read more →
Product

Certara Simcyp Simulator Results Replace Ten Human Trials for Ch

Certara's Simcyp Simulator has been used to replace ten human trials for the Chronic Myeloid Leukemia therapy, asciminib. The U.S. FDA accepted physiologically-based pharmacokinetic modeling predictions from the simulator, aiding the new drug application. This approach enhances drug development efficiency by simulating drug interactions and dosing regimens, supporting regulatory approval.

Read more →
Product

Certara Inc Announces Simcyp Simulator Results Replace Ten Human Trials ...

Certara Inc. announced that its Simcyp Simulator's physiologically-based pharmacokinetic (PBPK) modeling results have been accepted by the U.S. FDA to replace ten human trials for the drug asciminib, used in treating Chronic Myeloid Leukemia. This innovative approach supports the new drug application by predicting drug interactions and pharmacokinetics, enhancing regulatory decision-making and potentially expediting drug approval processes.

Read more →
Product

Certara Simcyp Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Certara's Simcyp Simulator has successfully replaced ten human trials for the Chronic Myeloid Leukemia therapy, asciminib, using physiologically-based pharmacokinetic modeling. This model-informed approach, accepted by the U.S. FDA, supports the new drug application by predicting drug interactions and optimal dosing. The collaboration with Novartis highlights the simulator's role in regulatory decision-making and drug development.

Read more →

Certara, USA. Profile

Company Name

Certara, USA.

Company Website

https://www.certara.com/

HQ Location

123 South Broad Street, Suite 1850, Philadelphia, PA 19109, US

Employees

11-50

Social

Facebook Linkedin Twitter

Financials

PRIVATE